<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 1997 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000316253
<NAME> ENZO BIOCHEM, INC.
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUL-31-1997
<PERIOD-START>                             AUG-01-1996
<PERIOD-END>                               JAN-31-1997
<CASH>                                          23,209
<SECURITIES>                                         0
<RECEIVABLES>                                   23,255
<ALLOWANCES>                                   (7,841)
<INVENTORY>                                      1,791
<CURRENT-ASSETS>                                42,716
<PP&E>                                           8,876
<DEPRECIATION>                                 (5,931)
<TOTAL-ASSETS>                                  64,620
<CURRENT-LIABILITIES>                            1,479
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           232
<OTHER-SE>                                      89,913
<TOTAL-LIABILITY-AND-EQUITY>                    64,620
<SALES>                                         15,734
<TOTAL-REVENUES>                                15,734
<CGS>                                            7,093
<TOTAL-COSTS>                                    9,341
<OTHER-EXPENSES>                                 6,775
<LOSS-PROVISION>                                 2,566
<INTEREST-EXPENSE>                             (1,038)
<INCOME-PRETAX>                                    338
<INCOME-TAX>                                        18
<INCOME-CONTINUING>                                320
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       320
<EPS-PRIMARY>                                      .01
<EPS-DILUTED>                                      .01